Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hagar, Sonego"'
Publikováno v:
Immunology Letters. 112:110-119
Inflammatory bowel diseases (IBDs) are complex multifactorial immunological disorders characterized by dysregulated immune reactivity in the gut and imbalance between pro-inflammatory and anti-inflammatory reactivity. The therapeutic effect of the im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0aaf57b2037a91084aaef14252a6949
https://doi.org/10.1016/j.imlet.2007.07.009
https://doi.org/10.1016/j.imlet.2007.07.009
Autor:
Eran Gilat, Ben Avi Weissman, David Alkalay, Hagar Sonego, Lily Raveh, Rachel Brandeis, Ishai Rabinovitz, Giora Cohen
Publikováno v:
Annals of the New York Academy of Sciences. 1025:584-589
Several drugs of abuse are known to produce an array of deleterious effects, including alterations in neuronal circuitry and, ultimately, neuronal degeneration. For instance, methamphetamine was shown to induce substantial nigrostriatal dopaminergic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20ef10aea1028ebadbb5306bc00fc68a
https://doi.org/10.1196/annals.1316.072
https://doi.org/10.1196/annals.1316.072
Autor:
Niva Natan, Nira Bar-Ner, Itzhak Marcovitch, Hagar Sonego, Rachel Brandeis, Abraham Fisher, Zipora Pittel, Rachel Haring, Inbal Egozi, Michal Kliger-Spatz
Publikováno v:
Journal of Molecular Neuroscience. 20:349-356
M1 muscarinic receptors (M1 mAChRs) play a role in an apparent linkage of three major hallmarks of Alzheimer's disease (AD): beta-amyloid (Abeta) peptide; tau hyperphosphorylation and paired helical filaments (PHFs); and loss of cholinergic function
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e248057e74a82b0a89fd32b3494b06f1
https://doi.org/10.1385/jmn:20:3:349
https://doi.org/10.1385/jmn:20:3:349
Autor:
Niva Natan, Itzhak Marcovitch, Rachel Haring Nira Bar-Ner, Hagar Sonego, Michal Kliger-Spatz, Abraham Fisher, Rachel Brandeis, Zipora Pittel
Publikováno v:
Journal of Molecular Neuroscience. 19:145-153
The M1 muscarinic agonists AF102B (Cevimeline, EVOXACTM: prescribed in USA and Japan for Sjogren's Syndrome), AF150(S) and AF267B--1) are neurotrophic and synergistic with neurotrophins such as nerve growth factor and epidermal growth factor; 2) elev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69c7c29934d68f9757c6099a183d5139
https://doi.org/10.1007/s12031-002-0025-3
https://doi.org/10.1007/s12031-002-0025-3
Autor:
Noëlle Bons, Niva Natan, Nira Bar-Ner, Itzhak Marcovitch, Hagar Sonego, Zipora Pittel, Rachel Brandeis, Rachel Haring
Publikováno v:
Cholinergic Mechanisms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72bef2cd0403c30ea60d21bbcef90289
https://doi.org/10.3109/9780203493878-50
https://doi.org/10.3109/9780203493878-50
Autor:
Eran Gilat, Ben Avi Weissman, Lily Raveh, Hagar Sonego, Giora Cohen, Rachel Brandeis, David Alkalay, Ishai Rabinovitz
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology. 75(1)
Soman, a powerful inhibitor of acetylcholinesterase, causes an array of toxic effects in the central nervous system including convulsions, learning and memory impairments, and, ultimately, death. We report on the protection afforded by postexposure a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3085242fc15aa0d55988ebdd8ed4c694
https://pubmed.ncbi.nlm.nih.gov/12832655
https://pubmed.ncbi.nlm.nih.gov/12832655
Autor:
Abraham, Fisher, Zipora, Pittel, Rachel, Haring, Nira, Bar-Ner, Michal, Kliger-Spatz, Niva, Natan, Inbal, Egozi, Hagar, Sonego, Itzhak, Marcovitch, Rachel, Brandeis
Publikováno v:
Journal of molecular neuroscience : MN. 20(3)
M1 muscarinic receptors (M1 mAChRs) play a role in an apparent linkage of three major hallmarks of Alzheimer's disease (AD): beta-amyloid (Abeta) peptide; tau hyperphosphorylation and paired helical filaments (PHFs); and loss of cholinergic function
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::debaa083b879ffce61b63e58aa4c0964
https://pubmed.ncbi.nlm.nih.gov/14501019
https://pubmed.ncbi.nlm.nih.gov/14501019
Autor:
Ben Avi Weissman, Hagar Sonego, Giora Cohen, Ishai Rabinovitz, Lily Raveh, David Alkalay, Rachel Brandeis
Publikováno v:
Neurotoxicology. 23(1)
Exposure to soman, a toxic organophosphate nerve agent, causes severe adverse effects and long term changes in the peripheral and central nervous systems. The goal of this study was to evaluate the ability of prophylactic treatments to block the dele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca25ef43461122e70507150a56fe6d34
https://pubmed.ncbi.nlm.nih.gov/12164550
https://pubmed.ncbi.nlm.nih.gov/12164550
Autor:
Nira Bar-Ner, Rachel Brandeis, Abraham Fisher, Niva Natan, Zipora Pittel, Rachel Haring, Nadine Mestre-Francés, Itzhak Marcovitch, Hagar Sonego, Noëlle Bons
Publikováno v:
Mapping the Progress of Alzheimer’s and Parkinson’s Disease ISBN: 9781475709735
M1 muscarinic receptors (M 1 mAChR) have an important role in cognitive processing relevant to Alzheimer’s disease brains (AD)1–5. M1 mAChR are relatively unchanged in AD1–5 and therefore may serve as a target for an anti-dementia drug treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69edea398f3b792def2ddf79169308a7
https://doi.org/10.1007/978-0-306-47593-1_34
https://doi.org/10.1007/978-0-306-47593-1_34
Autor:
Abraham Fisher, Z. Pittel, Michal Kliger-Spatz, Itzhak Marcovitch, Hagar Sonego, Rachel Brandeis, Rachel Haring, Nira Bar-Ner, Niva Natan
Publikováno v:
Ageing and Dementia Current and Future Concepts ISBN: 9783211837962
The Ml muscarinic agonists AF102B, AF150(S) & AF267B — i) restored cognitive impairments in several animal models for AD with an excellent safety margin; ii) elevated α-APPs levels; iii) attenuated vicious cycles induced by Aβ, and inhibited Aβ-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::844c1156e3e9f46a5da7b41acc28e670
https://doi.org/10.1007/978-3-7091-6139-5_18
https://doi.org/10.1007/978-3-7091-6139-5_18